Drug information for RIMIFON

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
INJECTABLE; INJECTION 100MG/ML Discontinued   ISONIAZID Isoniazid ROCHE 8420
INJECTABLE; INJECTION 25MG/ML Discontinued   ISONIAZID Isoniazid ROCHE   "
SYRUP; ORAL 50MG/5ML Discontinued   ISONIAZID Isoniazid ROCHE   "

Drug Adverse Effects information for RIMIFON

Role code Indications Reaction # Reports
SS ASPERGILLOSIS CHOLESTASIS 1
SS ASPERGILLOSIS JAUNDICE 1
SS BONE TUBERCULOSIS HEPATITIS FULMINANT 6
SS HEADACHE HEPATITIS FULMINANT 2
SS LUNG TRANSPLANT CHOLESTASIS 2
SS LUNG TRANSPLANT JAUNDICE 2
SS PULMONARY TUBERCULOSIS CHOLESTASIS 2
SS PULMONARY TUBERCULOSIS JAUNDICE 2
C ASPERGILLOSIS DRUG INTERACTION 2
C ASPERGILLOSIS DRUG LEVEL INCREASED 2
C ASPERGILLOSIS RENAL FAILURE ACUTE 2
C HEPATITIS C RHABDOMYOLYSIS 1
C HIV INFECTION BICYTOPENIA 2
C HIV INFECTION FANCONI SYNDROME ACQUIRED 2
C KERATITIS HERPETIC ALTERNARIA INFECTION 4
C KERATITIS HERPETIC CHOLESTASIS 4
C KERATITIS HERPETIC GRANULOMA 4
C KERATITIS HERPETIC HEPATIC FUNCTION ABNORMAL 4
C KERATITIS HERPETIC HEPATOTOXICITY 4
C KERATITIS HERPETIC LUNG DISORDER 4
C KERATITIS HERPETIC MYCOBACTERIUM KANSASII INFECTION 4
C KERATITIS HERPETIC SKIN LESION 4
C KERATITIS HERPETIC TRANSAMINASES INCREASED 4
C LATENT TUBERCULOSIS BICYTOPENIA 1
C LATENT TUBERCULOSIS FANCONI SYNDROME ACQUIRED 1
C LUNG TRANSPLANT DRUG INTERACTION 2
C LUNG TRANSPLANT DRUG LEVEL INCREASED 2
C LUNG TRANSPLANT RENAL FAILURE ACUTE 2
C MYCOBACTERIAL INFECTION RHABDOMYOLYSIS 4
C MYCOBACTERIUM KANSASII INFECTION ALTERNARIA INFECTION 3
C MYCOBACTERIUM KANSASII INFECTION CHOLESTASIS 3
C MYCOBACTERIUM KANSASII INFECTION GRANULOMA 3
C MYCOBACTERIUM KANSASII INFECTION HEPATIC FUNCTION ABNORMAL 3
C MYCOBACTERIUM KANSASII INFECTION HEPATOTOXICITY 3
C MYCOBACTERIUM KANSASII INFECTION LUNG DISORDER 3
C MYCOBACTERIUM KANSASII INFECTION MYCOBACTERIUM KANSASII INFECTION 3
C MYCOBACTERIUM KANSASII INFECTION SKIN LESION 3
C MYCOBACTERIUM KANSASII INFECTION TRANSAMINASES INCREASED 3
C OPPORTUNISTIC INFECTION PROPHYLAXIS DRUG INTERACTION 1
C OPPORTUNISTIC INFECTION PROPHYLAXIS DRUG LEVEL INCREASED 1
C OPPORTUNISTIC INFECTION PROPHYLAXIS RENAL FAILURE ACUTE 1
C PRODUCT USED FOR UNKNOWN INDICATION ALTERNARIA INFECTION 6
C PRODUCT USED FOR UNKNOWN INDICATION CHOLESTASIS 6
C PRODUCT USED FOR UNKNOWN INDICATION GRANULOMA 6
C PRODUCT USED FOR UNKNOWN INDICATION HEPATIC FUNCTION ABNORMAL 6
C PRODUCT USED FOR UNKNOWN INDICATION HEPATOTOXICITY 6
C PRODUCT USED FOR UNKNOWN INDICATION LUNG DISORDER 6
C PRODUCT USED FOR UNKNOWN INDICATION MYCOBACTERIUM KANSASII INFECTION 6
C PRODUCT USED FOR UNKNOWN INDICATION RHABDOMYOLYSIS 8
C PRODUCT USED FOR UNKNOWN INDICATION SKIN LESION 6
C PRODUCT USED FOR UNKNOWN INDICATION TRANSAMINASES INCREASED 6
C RESPIRATORY TRACT INFECTION RHABDOMYOLYSIS 4
C SUBSTANCE ABUSE RHABDOMYOLYSIS 1
C TUBERCULOSIS DRUG INTERACTION 2
C TUBERCULOSIS DRUG LEVEL INCREASED 2
C TUBERCULOSIS RENAL FAILURE ACUTE 2
Ads by Google